• Assessing recent developments in separation sciences from collaborations with academia: Examples in high resolution/high speed LC, high temperature LC and SFC • Continuous improvement in a development environment. • Determining tools and approaches for reducing overall cycle-times.
Jay Makwana, ARD Productivity, Innovation and External Collaborations Lead Associate Research Fellow, Pfizer Global R&D
• Screening and selection of the best form (polymorph, salt,cocrystal, amorphous, amorphous dispersion) • Characterisation and performance assessment • Development/formulation/processing issues to consider • Phase I example for a poorly soluble compound
Dr Ann Newman, Vice President of Research and Development, Aptuit